Literature DB >> 2261343

Identification of mRNA for PDGF B-chain in human megakaryocytes isolated using a novel immunomagnetic separation method.

A M Gladwin1, M J Carrier, J E Beesley, R Lelchuk, V Hancock, J F Martin.   

Abstract

A rapid and simple method has been developed for the separation of pure populations of intact human megakaryocytes from whole bone marrow. Megakaryocytes were specifically recognized using monoclonal antibodies coupled to magnetizable articles. Cells labelled with the magnetizable probe were separated from unlabelled cells by introduction of a magnetic field. The technique yields megakaryocyte suspensions with a purity of greater than 98%. Electron microscope examination showed that the ultrastructure of the isolated megakaryocytes was well preserved. Using this method of cell purification, we have investigated expression of the gene for platelet-derived growth factor (PDGF). RNA was isolated from cells harvested from either ribs or posterior iliac crest. The RNA was spotted onto nitrocellulose, and then hybridized using a c-sis riboprobe specific for PDGF B chain mRNA. We demonstrate that mRNA for PDGF B-chain is identifiable in samples of 50,000 cells. We conclude that PDGF is synthesized by the megakaryocyte.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2261343     DOI: 10.1111/j.1365-2141.1990.tb06364.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Reduced stimulability of platelet surface adhesion molecules under treatment with Lorenzo's oil.

Authors:  H Toplak; T C Wascher; B Pleschko; H Ramschak; P Sedlmayr; M Wilders-Truschnigg; S Stöckler
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

2.  Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells.

Authors:  M Yang; K Li; A C Lam; P M Yuen; T F Fok; C N Chesterman; B H Chong
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

3.  Identification and characterization of an essential, activating regulatory element of the human SIS/PDGFB promoter in human megakaryocytes.

Authors:  H M Jin; M L Brady; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 4.  The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes.

Authors:  John F Martin; Steen D Kristensen; Anthony Mathur; Erik L Grove; Fizzah A Choudry
Journal:  Nat Rev Cardiol       Date:  2012-11       Impact factor: 32.419

5.  A novel human c-sis mRNA species is transcribed from a promoter in c-sis intron 1 and contains the code for an alternative PDGF B-like protein.

Authors:  R P Dirks; C Onnekink; H J Jansen; A de Jong; H P Bloemers
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

6.  In vivo footprinting and functional analysis of the human c-sis/PDGF B gene promoter provides evidence for two binding sites for transcriptional activators.

Authors:  R P Dirks; H J Jansen; B van Gerven; C Onnekink; H P Bloemers
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

7.  Endothelial FAK is required for tumour angiogenesis.

Authors:  Bernardo Tavora; Silvia Batista; Louise E Reynolds; Shalini Jadeja; Stephen Robinson; Vassiliki Kostourou; Ian Hart; Marcus Fruttiger; Maddy Parsons; Kairbaan M Hodivala-Dilke
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137

8.  A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume.

Authors:  Yao Bo Yang; Jing Shen; Sheng Hai Wang; Jian Bo Song; Fangfang Ge; Jia Pei Xie; Jiang Shuai Qu; Xin Zu Mao; Zhao Cheng Kuang; Nan Shang; Xiang Wang; Ye Jun Wu; Fan Yang; Yue Yuan; Hongxin Wang; Jun Sun; Jicheng Fang; Liang Xiao
Journal:  BMC Cardiovasc Disord       Date:  2020-08-08       Impact factor: 2.298

Review 9.  Endothelial-Specific Cre Mouse Models.

Authors:  Sophie Payne; Sarah De Val; Alice Neal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.